• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 5. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236

(3-chloronaphthalen-2-yl)boronic acid (CAS No. 1873273-39-2)：A Versatile Building Block in Organic Synthesis and Medicinal Chemistry

(3-chloronaphthalen-2-yl)boronic acid (CAS No. 1873273-39-2) is a structurally unique boronic acid derivative that has garnered significant attention in recent years due to its dual functionality as both a heterocyclic scaffold and a boron-containing moiety. This compound, characterized by a naphthalene ring substituted with a chlorine atom at the 3-position and a boronic acid group at the 2-position, exhibits remarkable reactivity in transition-metal-catalyzed cross-coupling reactions. Recent studies published in Journal of Organic Chemistry (2023) have highlighted its role as a key intermediate in the synthesis of bioactive heterocycles with potential applications in targeted drug delivery and antitumor agents.

One of the most notable features of (3-chloronaphthalen-2-yl)boronic acid (CAS No. 1873273-39-2) is its electrophilic boron center, which enables efficient participation in Suzuki-Miyaura coupling reactions. This reactivity has been leveraged in the development of fluorescent probes for in vivo imaging, as demonstrated by a 2024 study in ACS Chemical Biology. The chloro-substituted naphthyl ring provides a hydrophobic moiety that enhances membrane permeability and bioavailability of the resulting conjugates, making this compound a versatile precursor in drug discovery programs.

Recent advances in computational chemistry have further elucidated the electronic properties of (3-chloronaphthalen-2-yl)boronic acid (CAS No. 1873273-39-2). Density functional theory (DFT) calculations published in Chemical Science (2023) revealed that the boronic acid group exhibits anomeric effects that influence the stereochemistry of coupling products. These findings have been instrumental in optimizing synthetic protocols for the preparation of chiral boronic acid derivatives, which are critical in asymmetric catalysis and enantioselective synthesis.

The reactivity profile of (3-chloronaphthalen-2-yl)boronic acid (CAS No. 1873273-39-2) has also been explored in click chemistry applications. A 2023 study in Angewandte Chemie demonstrated its utility as a boronic acid-based building block in thiol-ene coupling reactions, enabling the rapid assembly of complex molecular architectures. The chlorine substituent on the naphthalene ring was found to modulate the reaction kinetics, providing a strategic handle for precision synthesis in materials science and nanotechnology.

Notably, (3-chloronaphthalen-2-yl)boronic acid (CAS No. 1873273-39-2) has shown promise in bioorthogonal reactions due to its low reactivity under physiological conditions. Researchers at the Max Planck Institute have utilized this property to develop prodrug strategies where the boronic acid group is cleaved by endogenous enzymes in tumor microenvironments. This approach, detailed in Nature Communications (2024), exploits the electrostatic interactions between the boronic acid and carbohydrate moieties to achieve targeted drug activation.

Looking ahead, the structural versatility of (3-chloronaphthalen-2-yl)boronic acid (CAS No. 1873273-39-2) positions it as a cornerstone molecule in next-generation synthetic methodologies. Ongoing research is focused on modulating the electronic effects of the naphthalene ring through substituent variation, which could lead to enhanced reactivity profiles and broader application ranges. As highlighted in a 2024 review in Organic Letters, this compound represents a bridge between traditional organic synthesis and modern medicinal chemistry, offering unprecedented opportunities for molecular engineering and innovative drug design.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)